N-Acetyl-L-Glutamate

Identification

Summary

N-Acetyl-L-Glutamate is a glutamate derivate used to prevent allergic conjunctivitis.

Generic Name
N-Acetyl-L-Glutamate
DrugBank Accession Number
DB04075
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 189.1659
Monoisotopic: 189.063722467
Chemical Formula
C7H11NO5
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Prevention ofConjunctivitis allergic••• •••••••••••• •••••••• • •••••
Prevention ofConjunctivitis allergic•••••••••••••••••••• • •••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UAcetylglutamate kinaseNot AvailableEscherichia coli (strain K12)
UAcetylglutamate kinaseNot AvailablePseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Glutamic acid and derivatives
Alternative Parents
N-acyl-alpha amino acids / Fatty acids and conjugates / Dicarboxylic acids and derivatives / Propargyl-type 1,3-dipolar organic compounds / Carboxylic acids / Carboximidic acids / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives
show 1 more
Substituents
Aliphatic acyclic compound / Carbonyl group / Carboximidic acid / Carboximidic acid derivative / Carboxylic acid / Dicarboxylic acid or derivatives / Fatty acid / Glutamic acid or derivatives / Hydrocarbon derivative / N-acyl-alpha amino acid or derivatives
show 9 more
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
N-acetyl-L-amino acid, N-acyl-L-glutamic acid (CHEBI:17533)
Affected organisms
Not Available

Chemical Identifiers

UNII
MA61H539YZ
CAS number
1188-37-0
InChI Key
RFMMMVDNIPUKGG-YFKPBYRVSA-N
InChI
InChI=1S/C7H11NO5/c1-4(9)8-5(7(12)13)2-3-6(10)11/h5H,2-3H2,1H3,(H,8,9)(H,10,11)(H,12,13)/t5-/m0/s1
IUPAC Name
(2S)-2-acetamidopentanedioic acid
SMILES
CC(=O)N[C@@H](CCC(O)=O)C(O)=O

References

General References
Not Available
KEGG Compound
C00624
PubChem Compound
70914
PubChem Substance
46507366
ChemSpider
64077
BindingDB
50151383
ChEBI
17533
ChEMBL
CHEMBL1234751
ZINC
ZINC000001532704
PDBe Ligand
NLG
PDB Entries
1gs5 / 1gsj / 1oh9 / 1oha / 2bty / 2buf / 2jj4 / 2rd5 / 2v5h / 3b8g
show 13 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionOphthalmic0.049 g
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)199 °CPhysProp
Predicted Properties
PropertyValueSource
Water Solubility18.6 mg/mLALOGPS
logP-0.67ALOGPS
logP-1.1Chemaxon
logS-1ALOGPS
pKa (Strongest Acidic)3.43Chemaxon
pKa (Strongest Basic)-1.8Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area103.7 Å2Chemaxon
Rotatable Bond Count5Chemaxon
Refractivity40.73 m3·mol-1Chemaxon
Polarizability17.44 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption-0.6519
Blood Brain Barrier+0.9482
Caco-2 permeable-0.859
P-glycoprotein substrateNon-substrate0.6774
P-glycoprotein inhibitor INon-inhibitor0.959
P-glycoprotein inhibitor IINon-inhibitor0.9721
Renal organic cation transporterNon-inhibitor0.9592
CYP450 2C9 substrateNon-substrate0.7566
CYP450 2D6 substrateNon-substrate0.8581
CYP450 3A4 substrateNon-substrate0.6074
CYP450 1A2 substrateNon-inhibitor0.8971
CYP450 2C9 inhibitorNon-inhibitor0.9623
CYP450 2D6 inhibitorNon-inhibitor0.9684
CYP450 2C19 inhibitorNon-inhibitor0.9696
CYP450 3A4 inhibitorNon-inhibitor0.967
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9887
Ames testNon AMES toxic0.8822
CarcinogenicityNon-carcinogens0.942
BiodegradationReady biodegradable0.9179
Rat acute toxicity1.4388 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9878
hERG inhibition (predictor II)Non-inhibitor0.9761
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (3 TMS)GC-MSsplash10-0a4i-1940000000-78ee4843d1eab79c7ca3
GC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-0api-3930000000-e499004b087e5d741b02
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0006-9500000000-cdb488a97c5bf1952810
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a4j-0920000000-2d39b0eff0ff23756843
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0aor-1920000000-a2fe62d19e50f9db103f
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a4j-0920000000-546571923f012476b58b
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0ap0-1910000000-d18f7c4035b189c1f4b6
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a4r-1900000000-fc8347700abd012bf349
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-0900000000-1f9f80a37aa4e37ee878
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0fb9-0900000000-5423b76f7eb4b2a17fac
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0udi-2900000000-38410c884a2999611065
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0zfr-9700000000-85acd9611312dd7df0db
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0pb9-9100000000-0d780e23d772cf133da2
MS/MS Spectrum - , negativeLC-MS/MSsplash10-0ufr-1900000000-7a57de84cf9c6671cfc2
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0006-0900000000-7b58c7204405ece93fca
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001i-1900000000-515b33cc5674fc8985c8
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001i-9300000000-b379a6e4d794e810c478
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001i-9000000000-2ce098bb9e1b35433878
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001i-9000000000-8e7d8abde262b7d5cb45
MS/MS Spectrum - , positiveLC-MS/MSsplash10-001i-1900000000-a3bdc3627857c5f47f4b
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0f7k-0900000000-d8e577ef70becfc42cca
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-0900000000-9ec25070aef2d9bbe6e9
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0fba-2900000000-c5ef16785e52e8e18686
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0ue9-4900000000-d02f2bbe8b42d2918799
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-054o-9600000000-d6583e7bc971bdaa1525
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-63b3f60b96693a2304f6
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-143.6597014
predicted
DarkChem Lite v0.1.0
[M-H]-143.5495014
predicted
DarkChem Lite v0.1.0
[M-H]-143.4603014
predicted
DarkChem Lite v0.1.0
[M-H]-132.50642
predicted
DeepCCS 1.0 (2019)
[M+H]+142.9944014
predicted
DarkChem Lite v0.1.0
[M+H]+143.2720014
predicted
DarkChem Lite v0.1.0
[M+H]+143.9456014
predicted
DarkChem Lite v0.1.0
[M+H]+135.36151
predicted
DeepCCS 1.0 (2019)
[M+Na]+144.2773014
predicted
DarkChem Lite v0.1.0
[M+Na]+144.3862014
predicted
DarkChem Lite v0.1.0
[M+Na]+144.1970014
predicted
DarkChem Lite v0.1.0
[M+Na]+144.50029
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Escherichia coli (strain K12)
Pharmacological action
Unknown
General Function
Atp binding
Specific Function
Not Available
Gene Name
argB
Uniprot ID
P0A6C8
Uniprot Name
Acetylglutamate kinase
Molecular Weight
27159.285 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Kind
Protein
Organism
Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
Pharmacological action
Unknown
General Function
Atp binding
Specific Function
Not Available
Gene Name
argB
Uniprot ID
Q9HTN2
Uniprot Name
Acetylglutamate kinase
Molecular Weight
31848.87 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 08, 2021 11:32